SPECTRUM PHARMACEUTICALS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
SPECTRUM PHARMACEUTICALS INC had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $5.90 per share as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2023-05-11
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $5.90.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $6.64.
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $7.68.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $8.04.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2023-03-31 | $5.90 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.64 10-K · filed 2023-03-31 |
| 2022-09-30 | $7.68 10-Q · filed 2022-11-14 |
| 2021-12-31 | $8.04 10-K · filed 2022-03-18 |
| 2020-12-31 | $8.65 10-K · filed 2021-03-31 |
| 2019-12-31 | $8.66 10-K · filed 2020-03-02 |
| 2018-12-31 | $7.87 10-K · filed 2019-02-28 |
| 2017-12-31 | $7.00 10-K · filed 2018-03-07 |
| 2016-12-31 | $6.99 10-K · filed 2017-03-14 |
| 2015-12-31 | $6.94 10-K · filed 2016-03-14 |
| 2014-12-31 | $6.62 10-K · filed 2015-03-13 |
| 2013-12-31 | $6.11 10-K · filed 2014-03-12 |
| 2012-12-31 | $5.34 10-K/A · filed 2013-12-06 |